EXALGO- hydromorphone hydrochloride tablet, extended release 
Mallinckrodt, Inc


Medication Guide

EXALGO® (eks-al-goh) (hydromorphone hydrochloride) extended-release tablets, CII


Important information about EXALGO:

Do not take EXALGO if you have:

Before taking EXALGO, tell your healthcare provider if you have a history of:

Tell your healthcare provider if you are:

When taking EXALGO:

While taking EXALGO, DO NOT:

The possible side effects of EXALGO are:

Get emergency medical help if you have:

These are not all the possible side effects of EXALGO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov

Trademarks are the property of a Mallinckrodt company.

Distributed by: Mallinckrodt Brand Pharmaceuticals, Inc., Hazelwood, MO 63042 USA, www.Exalgo.com or call 1-800-778-7898


This Medication Guide has been approved by the U.S. Food and Drug Administration.  

Revised: April 2014

Revised: 4/2014
Mallinckrodt, Inc